Healthcare

Developing the next generation of oncology therapies for patients.

We're dedicated to defeating cancer with therapies that target disease, not immune systems. Find our investigational immunotherapy and cell therapy products.

Novartis completed its acquisition of Avidity Biosciences in 2026, folding the San Diego RNA-therapeutics company into its late-stage neuroscience pipeline.

Crinetics is here for endocrine disease patients who are eager to find therapies that provide effective disease control and more simplicity in their lives.

Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.

Merck agreed to acquire the San Diego biotech for approximately $9.2 billion in November 2025.

Founded in 2012 by two UC San Diego PhD alumni, Jared Tangney and Josh Windmiller, originally under the name Electrozyme.

Co-founded by Drew Weissman, the 2023 Nobel Prize winner in Physiology or Medicine for mRNA vaccine research, alongside CAR-T pioneer Carl June; the company was later acquired by AbbVie.

Science Seralutinib Seralutinib is an inhaled PDGFRα/β, CSF1R, and c‑KIT inhibitor designed to be delivered via dry powder inhaler for the potential treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Founded by Ken Song and launched with over $370 million (later exceeding $500 million) from investors including Venrock Healthcare Capital Partners, RA Capital Management, and Fairmount.

Anchored by our protein-engineering expertise and our proprietary single-domain antibody platform, we’ve developed a unique pipeline of therapeutic candidates.

Has raised over $350 million from major healthcare investors including OrbiMed, BlackRock, and Bain Capital Life Sciences.

Co-founded by CEO Todd Harris and COO Daniel Bensen, and was incubated by venture firm Alta Partners before going public.

ABA therapy and comprehensive autism care for children, from diagnosis through developmental and medical therapy. Physician-led and in-network. Find a center near you.

We are on a mission to exponentially improve the number of quality years for patients.

Founded in 2019 with co-founder Dave Licata, and has raised over $450 million total, with investors including Goldman Sachs Asset Management and Blue Owl Capital.

Equip was co-founded by CEO Kristina Saffran, who drew on her own recovery from anorexia; she previously co-founded the nonprofit Project Heal. Actress Kerry Washington has also personally invested in the company.

We are a biopharmaceutical company focused on the development of proprietary cannabinoid derivatives for the treatment of glaucoma and other diseases with significant unmet medical needs. Our innovative approach to drug development combines strong science with the drive to find solutions where the need is the greatest.

Lightship is a clinical trial site network that expands participant choice through in-clinic, hybrid, virtual, and mobile research models.

Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.

Pelage raised a $120 million Series B co-led by ARCH Venture Partners and Google's venture arm GV, with GV's Cathy Friedman appointed board chair.

Endeavor BioMedicines is a clinical-stage biotechnology company developing transformational medicines for life-threatening diseases.

Renovaro revolutionizes cancer and neurology care through early detection, drug discovery, and personalized treatments. AI-powered precision medicine.

A Foresite Labs-incubated biotech backed by Foresite Capital, Qiming Venture Partners, and Samsara BioCapital that raised over $100M before being folded into Candid Therapeutics' $370M launch in 2024.

Autobahn aims to improve life health for people affected by CNS disorders by driving the regenerative power of the human body.

JenaValve's investors include Bain Capital Life Sciences and the Qatar Investment Authority.

We at Boundless Bio are pioneers in understanding and treating the most intractable cancers. We have charted a new spatial map of the cancer genome within cancer cells and are harnessing our scientific founders’ discoveries about “extrachromosomal DNA,” or ecDNA, to drive a revolution in cancer therapeutics.

No math. No dosing decisions. Just freedom to live.

Enlaza Therapeutics is pioneering the field of covalent biologics, developing a novel classes of protein therapeutics based on its proprietary War-Lock™ platform.

NeOnc is a clinical-stage life sciences company developing a novel intranasal drug delivery system and platform technology to treat brain cancers and other central nervous system (CNS) diseases by bypassing the Blood-Brain Barrier (BBB).

TRC 2004 was co-founded by Third Rock Ventures and Two River, the same investor group behind Kite Pharma (sold to Gilead for roughly $11.9B), and later emerged publicly as Candid Therapeutics with a $370M capital raise.

Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and treat metabolic

Proactive health memberships combining Whole Body MRI, advanced blood biomarker testing, and ongoing clinical guidance—designed to help you track your health year over year.

Rebuilding healthcare with AI at the core

Part of the NantWorks ecosystem of biotech and health companies founded by billionaire physician-entrepreneur Patrick Soon-Shiong, who also owns the Los Angeles Times and invented the cancer drug Abraxane.

Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.

Gene therapy company that emerged from stealth in June 2023 with a $51M Series A co-led by Westlake Village BioPartners, developing AAV-based genetic medicines for muscle and heart disease.

Co-founded by biomedical engineer Robert S. Hillman, PhD; developing devices/therapies to get STEMI heart-attack patients to treatment with open coronary arteries, and has raised $58.4M.

San Diego biologics company led by CEO Krisztina Zsebo, PhD, developing vascular biologic therapies for ischemic stroke and acute cardiovascular disease.

Plexium is a next-generation targeted protein degradation (TPD) company that discovers Monovalent Direct Degraders and Molecular Glues.

Co-founded in 2018 by Scott Glenn and Lauren Otsuki, the skincare-tech company (parent of the Ourself brand) is backed by Lightspeed Venture Partners and added former Allergan CEO Brent Saunders to its board.

Disrupt Pain Without Opioids. While other treatments dull pain, Latigo’s solutions target the source of pain before it reaches the central nervous system. The result is healing without dependence, and relief that can help restore quality of life.

Eledon Pharmaceuticals was co-founded and is led by CEO David-Alexandre Gros, a physician and serial biotech entrepreneur, with investors including BVF Partners, RA Capital Management, and Blue Owl Capital.

Discover how Immunis, a private biotechnology company is developing new secretome products for the treatment of age-related immune dysfunction

Oncocyte is a publicly traded diagnostics company (Nasdaq: OCX) that later renamed itself Insight Molecular Diagnostics and relocated its headquarters to Nashville.

SRT Therapeutics was founded in 2024 by former leaders of Prometheus Biosciences, including President & CEO Lauren Otsuki, and launched with roughly $47M in funding.

Restora Medical was founded by Dr. Quan Ni, who previously co-founded Inspire Medical Systems (Nasdaq: INSP).

Ceresti reduces hospitalizations and medical costs for people living with dementia by activating family caregivers to detect changes in the patient's condition.

Co-founded by Anton Kittelberger and Frank Westermann, who himself lives with diabetes; backers include Define Ventures and 7Wire Ventures.

Protego Bio is a clinical-stage biotech developing first-in-class small molecule pharmacological chaperones for AL amyloidosis and other protein misfolding diseases.

The most comprehensive executive health assessment — full-body MRI, whole genome sequencing, 120+ biomarkers & AI analysis in one visit. Starting at $8,000.

At Heron, we aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies to deliver medicines that matter.

Discover vMap - The FDA-Cleared Non-Invasive AI-based Arrhythmia Analysis Solution by Vektor Medical. Improve Cardiac Ablation Efficiencies & Outcomes Today.

Elevating senior healthcare together. Discover comprehensive primary care, preventive care, behavioral health and more. Partner with us for a healthier future.

California-based IV therapy manufacturer serving hospitals, IDNs, and medical device OEMs across North America. ISO13485 certified with 50+years of expertise.

The U.S. operating arm of CODAN Companies, a Danish medical device manufacturer founded in 1939, with its American headquarters in Santa Ana, CA.

Founded and led by Dr. Quyen Nguyen, a UC San Diego head-and-neck surgeon named to Forbes' 50 Over 50 Innovation list.

Modifying lipid-signaling pathways to improve treatments for people living with cancer

858 Therapeutics (its name references San Diego's 858 area code) has raised $110M across Series A and B rounds led by Versant Ventures and Avidity Partners, with participation from NEA and Insight Partners.

Poseida Therapeutics, a San Diego cell and gene therapy company founded by Eric Ostertag and once listed on Nasdaq as PSTX, was acquired by Roche in a December 2024 tender offer at $9.00/share cash plus a contingent value right.

AI-powered risk adjustment software designed to increase the profitability of Medicare risk contracts.

Serimmune was founded by Patrick Daugherty, a former UC Santa Barbara chemical engineering professor who also co-founded CytomX Therapeutics; backers include Illumina Ventures, LabCorp, and Merck.

The key to managing cancer is early detection. ClearNote Health makes this possible by finding signals of cancer in the blood early

German skincare giant Beiersdorf (maker of Nivea) became an investor in the company; Amicrobe later rebranded as Macro Biologics.

Lumati is a global holistic wellness optimization platform redefining longevity through science, technology, and personalized care — supporting cellular health, promoting recovery, and sustaining vitality.

Pictor Labs is The Virtual Staining Company enabling digital pathology adoption through computational virtual staining technology that preserves tissue for comprehensive downstream analysis.

SYLKE® Skin Closure is a sterile, single-use, silk fibroin mesh strip with a pressure-sensitive adhesive intended for topical skin closure and wound support. The device is used to hold together well-approximated skin edges of a wound, and to cover and protect the wound. Learn more at sylke.com.

ThinkBio.Ai is an AI-powered healthcare and life sciences solutions company, transforming complex data into actionable insights for better, faster decision-making.

Kiora Pharmaceuticals is a publicly traded, clinical-stage biopharmaceutical company (Nasdaq: KPRX) developing treatments for retinal disease, led by CEO Brian Strem.

Rapalogix is advancing a portfolio of TORC1-selective therapies and pro-longevity skincare products, addressing skin aging and disease at the root to extend skin healthspan.

Founded by Dr. Stella Sarraf; its ALS drug candidate SPG302 received an FDA-authorized expanded access program in 2025.

Paulex Bio stands at the threshold of what could be a transformative breakthrough for type 1 and type 2 diabetes: beta cell regeneration through an oral medicine designed to eliminate the root cause of diabetes.​

ClearPoint Neuro is a global therapy-enabling platform for navigation & delivery to the brain. When Your Path Is Unclear, We Point The Way.™

Its co-founders include one of the founders of Kite Pharma, which was acquired by Gilead for $12 billion.

AristaMD empowers primary care providers with excellent specialty care - improving patient outcomes with timely, cost-effective access.

At Daré Bioscience, women’s health is our mission. From clinical trials and non-hormonal contraception to therapies for menopause and vaginal dryness to vaginal health, our research is evidence-based and built exclusively for women.

Tempo Therapeutics is a biotechnology and tissue engineering company based out of San Diego, CA specializing in speeding up patient recovery.

Astiva Health, a Costa Mesa Medicare Advantage HMO, was co-founded by physician Dr. Tri Nguyen (CEO) and Chi Luong, and reported 188% membership growth to over 30,000 members.

Model Medicines engineers first-in-class small molecules against biological choke points, using AI to advance pipeline-in-a-pill therapeutics across high-impact diseases.

Price transparency and plan design tools for self-funded health plan comparisons and enhanced employee benefits strategies.

Syndex Bio was founded by Geoff Smith and raised a $15.5M seed round backed by ARCH Venture Partners, one of the top-tier biotech venture firms.

The Data Intelligence Network for Healthcare OutcomeMD’s Patient Experience Data Network™ turns de-identified patient-reported outcome measures (PROMs) into act

Primrose Bio specializes in innovative manufacturing solutions for biotherapeutics and vaccines, setting new standards for quality and production efficiency.

We explore the immense therapeutic opportunities to help those bound by autoimmune neuropsychiatric diseases.

In only five minutes and a penny-sized patch, Mindera Health technology captures thousands of RNA transcripts. We enable scalable collection and analysis of individualized genetic information to provide actionable, data-driven decisions for patients, providers and payers.

Valora Therapeutics is developing AbLec™ multispecific antibodies and T-Lec™ T cell engagers — antibody-engineering platforms that decoy the glyco-immune checkpoint to create best-in-class therapeutics for cancer and autoimmune disease.

Founded by physician-entrepreneur Remo Moomiaie-Qajar, M.D.; the San Diego biotech has raised $14.4M in funding, including from Partners Investment.

Syrna Therapeutics is pioneering a new class of mRNA targeting therapeutics that stop expression of disease-causing proteins

Founded by Atandra Burman, the Carlsbad, California company is developing a transdermal wearable for early detection of heart attacks.

Founded by entrepreneurs Simon Arkell and Alex Dickinson with seed funding from AIX Ventures and Page One Ventures; the company later rebranded as Ryght.

Cooler Heads is the creator of Amma™, an FDA-cleared scalp cooling system that helps cancer patients reduce hair loss during chemotherapy. Amma delivers hospital-grade cold-cap therapy that’s simple, portable, and patient-first.

Digital Surgery Systems, Inc. is the legal name behind True Digital Surgery, a Goleta, CA maker of 3D robotic-assisted surgical microscopy systems that was fully acquired by German medical device company B. Braun SE in September 2025.

AeroRx Therapeutics is developing potential best-in-class nebulized combination therapies to improve COPD treatment.

Leading the fight against cancer with targeted stem cell and viral therapies that activate the immune system to destroy solid tumors and metastatic disease.

We bring cell therapies to patients through innovative point-of-care manufacturing solutions.

Information about Elite Health Plan

Avicena was founded in 2019 by Bardia Pezeshki and raised a $65M Series B led by Tiger Global with participation from SK Hynix and Prosperity7 Ventures.

Learn how Genomic Life enhances health and well-being through genetic screenings, early detection, personalized cancer navigation, and ongoing support. Optimize employee benefits and create a healthier workforce.

DermOQ was founded by Bradley Patt, who previously served as CEO of medical imaging company Gamma Medica.

SLAM BioTherapeutics, an oncology biotech based in Westlake Village, CA, was co-founded by Dr. Steven T. Rosen, a prominent cancer researcher affiliated with City of Hope, alongside CEO Rick Heinick.

Bringing Confidence to your Prostate Cancer Treatment Decisions A revolutionary platform that delivers tailored insights for prostate cancer management,

Celestial Therapeutics is developing novel therapies based on innovative and groundbreaking science to treat, prevent and cure infectious diseases, rare diseases and cancers.

EpiPlex™ assay detects RNA modifications by proximity barcoding and short read RNA sequencing, revealing insights into gene regulation for disease research.

We are a pioneering biotechnology company dedicated to producing innovative solutions to treat traumatic nerve injury.

The Tally Surgical retained sponge prevention solution utilizes UHF RFID to simplify and speed an accurate count of surgical sponges and towels.

Tele911 integrates emergency medicine telehealth and patient navigation into 911 & EMS systems.

Cellibre, a San Diego biotech founded by CEO Ben Chiarelli in 2019, closed an $11.5M Series A led by Merida Capital Holdings to commercialize lab-cultured (fermentation-based) cannabinoids.

Qureator provides integrated human disease model and AI platform to evaluate treatment efficacy in complex disease models.

Independa Health Hub® is a simple to use ecosystem of health & wellness benefits on any screen — TV, tablet, computer, or phone. Many benefits absolutely FREE!

Developing novel long-acting therapeutics targeting chronic cardiometabolic diseases.

Gain unprecedented kinetic insights into your CRISPR workflow with the CRISPR QC’s analytics platform

EyeArt by Eyenuk is an autonomous, FDA-cleared AI for diabetic retinopathy screening and disease detection at the point of care.

Evofem’s mission is to empower women by providing products that give women the control and flexibility they desire

selectION Therapeutics' si-544 is a first-in-class Kv1.3 blocker and the first disease modifying treatment for T cell autoimmunity. Autoimmunity affects millions worldwide, but current treatments leave the root cause untouched. si-544 is the first therapy to safely and selectively deactivate disease-causing T cells, while preserving immune competence.

Ospitek empowers surgical centers with real-time IoT and AI-enhanced solutions, improving workflow efficiency, patient care, and staff coordination. Seamlessly integrate with legacy systems and unlock unparalleled operational visibility with Ospitek’s cutting-edge platform.

Preventive health platform for dogs. AI Health Companion, at-home blood draws & 40+ biomarker panel. Vet-built care plans for early disease detection.

Already a publicly traded company on Nasdaq (ticker: GYRE), not a typical early-stage startup; it recently completed an acquisition of Cullgen to create a combined US/China drug-development operation.

Founded and led by Dr. Sheila Gujrathi, a physician-scientist and serial biotech executive who also founded/chairs Vidya Therapeutics and Lila Biologics and sits on the board of Janux Therapeutics; the company is based in Encinitas, CA.

Co-founded by CEO Sam Alworth and Dr. Qing Liu; this ALS/FTD biotech was awarded $7.5M in grant funding from California's stem cell agency (CIRM) toward its first human trial, on top of earlier NIH and DOD funding.

Excellos Labs is a cell therapy CDMO offering apheresis collection, PBMC and leukopak processing, T/NK cell isolation, and cGMP manufacturing for biotech and pharma.

California Compounding is a trusted compounding partner for telehealth and clinics, offering office stock programs, prescriber portals, and scalable fulfillment.

Transposon Therapeutics, Inc. is developing TPN-101 (also known as Censavudine) and other LINE-1 reverse transcriptase inhibitors for the treatment of rare neurodegenerative diseases such as progressive supranuclear palsy (PSP), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD).

XiltriX provides 24/7 live agent monitoring for biotech and biopharma labs and facilities that need to prevent sample loss and maintain compliance.

Founded by Dr. Faith H. Barnett, the San Diego biotech has received investment from NuFund Venture Group.

Nasdaq-listed (QLGN); received a $41 million strategic PIPE investment from Faraday Future, whose founder is Chinese entrepreneur YT Jia (Jia Yueting).

Founded in 2016 by CEO Matt Lashey, who created the chemoWave cancer-treatment tracking app; investors include Plug and Play Tech Center.

Norwegian medical device company Photocure ASA announced in 2026 it is acquiring Vesica Health, whose bladder-cancer diagnostic AssureMDx has received FDA Breakthrough Device Designation.

Founded in 2007 by cardiothoracic surgeon Dr. Edward Boyle and Paul Molloy to develop anti-occlusion surgical drainage devices; the Anaheim-based company's PleuraFlow system was later distributed exclusively in the US by Maquet Medical Systems.

Co-founded by Shane Shahrestani, incubated through Caltech's OTTCP startup program; the company closed an oversubscribed $5M Series Seed Prime round in 2024 backed by investors including Freeflow Ventures and DigiTx Partners.

AI-driven medical coding from Synaptec Health - a more accurate, secure, and comprehensive solution for all your medical coding needs.

Tenovi remote patient monitoring 40+ FDA-cleared hardware devices power RPM and RTM programs with the first plug-and-play Cellular Gateway.

Founded in 2018 by Dr. Virender K. Sharma, a serial medtech entrepreneur and former Mayo Clinic professor, alongside CEO Dr. Holger Friedrich; the company develops single-shot catheter ablation technology for atrial fibrillation.

Acurion's OncoGaze™ technology delivers critical genomic insights at the biopsy stage, empowering oncologists to make precision therapy a reality for more patients.

Why Use the Virchow Medical Crow’s Nest Biopsy Catchment System? To Improve Core Needle Biopsy Collection, Tissue Management, and Access to Targeted Diagnostics.

Meduloc was founded by orthopedic hand surgeon Dr. Joshua Hustedt along with Cor Medical Ventures, and raised a $4M Series B led by GenHenn Capital.

ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs, physicians, and patients to access actionable biomarkers faster and more affordably. With HDPCR™, you can get critical and complete data, analyzed with simplicity, without paying for excess information.

Founded in 2022 by CEO Alex Speiser; backed by investors including Boost VC, Capital Factory, Gaingels, Healthspan Capital, and Mystic Ventures.

Precision fit and fully alignable. Unbelievably durable, versatile and affordable. It’s time for the UniLeg.

Co-founded by Jeffrey Port and William Blair; the company was acquired by Merit Medical Systems, expanding Merit's therapeutic oncology portfolio.

Virgo builds frontier AI models to solve diseases mediated by the gut. Our flagship model, EndoDINO, was trained on the largest GI endoscopy dataset.

Certis Oncology Intelligence: predictive AI + advanced cancer models for more insightful data. Translational science, done differently.

Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) is a clinical-stage pharmaceutical company developing a new class of oncology treatments and cancer therapies called PP2A inhibitors.

Kairos Pharma develops novel therapies to combat cancer drug resistance and restore immune response, advancing innovative treatments for cancer patients.

The majority of molecules sequenced are uninformative. Jumpcode Genomics is changing that by helping researchers boost usable NGS data.

Does business as Mahmee, a maternal health startup co-founded by Melissa Hanna that raised $3M in seed funding from Mark Cuban and Serena Williams.

Laguna Tech USA is an Irvine-based transcatheter heart valve company led by CEO Gilbert Madrid; it has raised over $8M, including investment from MedTech Innovator.

Illudent (operating as Illudent Therapeutics), a San Diego cancer-treatment biotech, has raised roughly $3.25-5.2M in funding from investors including Ulu Ventures and SeedFolio.

VivaMed BioPharma is a clinical-stage biopharma advancing new chemical entities and repurposed drugs across neurology, pain, psychiatry, pulmonology, and rheumatology. Operator-led development, global partnerships.

Effortless, science-backed oral microbiome insights from saliva. Decode your saliva for personalized wellness.

Ocelot Bio closed a $36M Series A led by RA Capital Management, Venrock, and Vivo Capital.

Amydis is the leader in developing a new class of diagnostic compounds that enable digital detection and monitoring of human disease-related molecular biomarkers through standard ocular imaging cameras.

Co-founded by CEO Scott Stout, recognized as one of 2021's top healthcare innovators, and Dr. Dennis Patterson; the El Segundo company builds decentralized clinical-trial technology.

Biologic solutions to optimize enthesis reformation, EnFix® is the future of bone to tendon healing.

Discover OrthoRPM, transforming home exercise programs with guided rehabilitation, motion tracking, and connected digital therapy solutions for clinics without paper.

CARI Health empowers clinicians to personalize methadone dosing for every patient.

SureCount SmartTrays streamline surgical instrument management, reducing errors, speeding counts, and improving safety across OR and SPD teams.

Co-founded in 2017 by Paul Kim, an Army veteran, the teletherapy company raised a $13M Series A led by Volition Capital.

Formerly operated Gamma Knife stereotactic radiosurgery centers; the publicly traded company (OTC: USNU) renamed itself Elite Health Systems Inc. in September 2024.

Founded by Thomas Estok and Dr. Mohamed Ragab, the cancer-drug developer has raised about $59M from investors including Deerfield Management and i&i Biotech Fund.

This entity is tied to Emergency Care Partners, which is majority owned by private-equity firm Varsity Healthcare Partners and received a structured equity investment from MidOcean Partners in 2025.

Aethlon Medical is a publicly traded company on Nasdaq under the ticker AEMD.

Transforming medicine through cellular therapies that restore, regenerate, and repair tissues and organs

AscentX Medical was founded by Dr. Stefan Lemperle and has raised over $10 million, including a grant from the European Union's Horizon 2020 program.

Founded by Ryan Davies in 2021 and led by CEO Byron Elton, the company has raised funds through equity crowdfunding on StartEngine.

Discover Allevion Therapeutics’ Allevx™ Smart-Band, a wearable device designed to reduce movement-related disorders due to Essential Tremor.

Navega Therapeutics was founded in 2018 by Ana Moreno along with UC San Diego bioengineering professor Prashant Mali, developing gene therapies for chronic pain; it has received a CIRM grant to support its work.

Discover delicious and nourishing Oatmilks, Almondmilks, Creamers, Coffees, and other natural, non-GMO beverages from Califia Farms. We’re dedicated to powering your wellness transformation by innovating better forms of nourishment with delicious dairy-free plant-based products.

Paralos Bioscience, co-founded by Yanxi Yang, is developing a phage-drug conjugate platform targeting drug-resistant infections and has been backed by Carbon Silicon Ventures, Larta Institute, Incate, and UCLA's Magnify program.

BRT Biotechnologies was co-founded by CEO Jane Liu, a tenured professor, and LA-based biotech operator Gregory Copeland, and counts StoryHouse Ventures and Springboard Enterprises among its investors.

Share medical imaging 99% faster and 100% digitally with the world's first digital films fulfillment platform.

Take control of your health. Reduce pain. Stress less. Improve focus. SHIFT.

Impulse Medical Technologies - A leading manufacturer and distributor of high-quality medical electrodes and diagnostic supplies. Parent company of The Electrode Store and TES Wholesale.

SeqOnce was co-founded in 2014 by Chris Angermayer and Joseph Dunham as a spinout from the University of Southern California, and has drawn investment from Wavemaker 360 Health and Mount Wilson Ventures.

BioSig Technologies (Nasdaq: BSGM), originally a medical-device company, pivoted into real-world-asset tokenization through a 2025 merger with Streamex Exchange, backed by mining financier Frank Giustra as a strategic advisor.

GRI Bio is a publicly traded clinical-stage biopharmaceutical company (Nasdaq: GRI), led by CEO Marc Hertz, PhD.

Nano porous silicon particles for controlled release drug delivery for the treatment of ocular diseases such AMD and for application to oncology

Berman Medical is a San Diego medical-imaging AI startup founded in 2024 by co-founder and CEO Andrew Hanna, and has raised about $607K to date.

Azora Therapeutics, an LA biopharma founded in 2019 by Matt Davidson and Julie Saiki, was acquired by Adial Pharmaceuticals in 2026 for up to $64 million.

Developing Life-Changing Therapeutics For Our Pets Monoclonal antibodies (mAbs) for modern veterinary practices Developing Life-Changing Therapeutics For Our Pets Monoclonal... Read More

GABA Therapeutics partnered with atai Life Sciences (co-founded by Florian Brand) in a Series A deal worth up to $15.5 million to develop a novel anxiety treatment; it was co-founded by Richard Farrell.

Explore Persperion for innovative sweat sensing technology and metabolic health monitoring at your fingertips.

LungLife AI is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence.

Our mission is to provide a compassionate, world-class customer experience to the families we serve.

Founded by brothers Dr. Josep Oliva and Dr. Xavi Oliva; the company makes the CeraRoot metal-free ceramic (zirconia) dental implant system.

Unlocking the microbiome for better skin health The Human Body Relies On The Microbiome For: Inflammation Control Infection Protection Wound Healing And More The Microbiome Cannot Be Ignored For over 100 years, "skincare" has often treated

Discover Trethera’s breakthrough therapy TRE-515 for autoimmune, oncology, and neuroinflammatory diseases. Learn about our science-driven innovation.

My Village Innovations (MVI Medical) is a women-led medical device company co-founded by Andrea "Annie" Munoz, PA-C, and Alfonso Munoz, focused on reimagining the vaginal speculum for gynecologic care.

Operated as "The BXNG Club," a luxury boxing gym chain in San Diego; the company filed Chapter 11 bankruptcy in June 2024 and abruptly closed all its remaining locations.

Robin Capital backs ambitious founders at Angel to Series A. We invest in grit, software, and vision—supporting startups with capital, experience, and founder-first values.

Co-founder Dr. H. Kirk Hammond of UC San Diego previously co-founded Collateral Therapeutics; CEO and co-founder Jack W. Reich received an Entrepreneur of the Year award.

Founded by MaryRose Reaston (co-founder/CSO) alongside CEO Brett Ottemeier; the Carlsbad-based company makes functional EMG diagnostic technology and has won an industry innovation award.

Unlocking New Indications for the in vivo CAR-T Modality

Founded by Jongdae Lee, a San Diego/Encinitas-based researcher and CSO with over 20 years of experience working on inflammatory disease drug development, including viral and bacterial infections and Crohn's disease.

Serafin Labs is a San Diego cancer-therapeutics company founded by CEO Sural Ranamukhaarachchi (UC San Diego bioengineering PhD) and affiliated with UCSD's Fraley Lab; it is still operating in stealth mode.

Intrigue Health, a San Diego home-diagnostics startup, was founded by Dereck Tatman, Ph.D., MBA, who brings over 25 years of industry experience to the company.

Phythera Therapeutics, Inc. is a biotechnology company leveraging the power of natural compounds to modulate key biological pathways in cancer and tissue regeneration to improve human health.

Founded by Dr. Susanne B. Nicholas, a UCLA nephrology professor, to commercialize kidney-disease research from her own lab.

Founded and led by Ilya Rachman, a physician-scientist and former UCLA clinical faculty member; the company trades publicly on Nasdaq under ticker IMMX.

MedCrypt gives medical device vendors cybersecurity features in a few…

Scheduling and workforce management SaaS for home healthcare providers

Bioengineered kidneys for patients with kidney failure

Fermentation-derived natural products to solve health problems

Healthcare Price Transparency APIs and Data Products

Creating a New Class of Drugs to Address Incurable Autoimmune Diseases

Government-funded online addiction treatment

CRISPR powered Diagnostics with results in minutes.

Float is the full-stack platform for Specialty Pharma

A new way of seeing inside the human body.

We are using the gut microbiome to end cancer.

The API for Diagnostic Test Analysis (COVID-19, FLU, RSV, STD,…

A small sticker that monitors blood pressure continuously

Our mobile app reduces chronic pain for 100 million Americans.

Oral drugs to halt neurodegeneration

Reinventing respiration monitoring

ML to predict and prevent pregnancy complications

High quality mRNA for therapeutic application

Responsive materials, better lives.